Tower Holdings B.V ceases to be a shareholder in SHL. Its representative Mr. Hagai Shilo to leave Board of Directors

Tower Holdings B.V ceases to be a shareholder in SHL. Its representative Mr. Hagai
Shilo to leave Board of Directors

Tel Aviv/Zurich, 30 April, 2012 – SHL Telemedicine Ltd. (SIX Swiss Exchange: SHLTN), a
leading provider and developer of advanced personal telemedicine solutions (“Company”),
today announced that Tower Holdings B.V. (“Tower”), a holder of approximately 10.9%1 of
the Company’s shares and which is deemed a controlling shareholder of the Company, has
notified that it has sold its entire holdings in SHL. As a result, the aggregate holdings of the
controlling shareholders of the Company in the issued and outstanding share capital of the
Company will decrease from approximately 47%1 to 36%1. In addition, Mr. Hagai Shilo,
appointed as a director by Tower, will resign from the Board of Directors. Mr. Shilo has been
serving as a Director on SHL’s Board since 2010.

Elon Shalev, Chairman of the Board of SHL, commented: “On behalf of the whole Board of
directors, I would like to thank Hagai for his service and contribution in the continued success
of the Company. We wish him the very best.”

About SHL Telemedicine
SHL Telemedicine Ltd. specializes in developing and marketing advanced personal telemedi-
cine systems as well as providing comprehensive telemedicine solutions including medical
call centers to individuals and to the healthcare community. As a leading provider of remote
health services in cardiology and in other medical areas, SHL maintains business operations
in Europe, mainly in Germany, and at its home market in Israel. In the US, certain SHL
telemedicine products are distributed by Philips Healthcare. SHL is listed on the SIX Swiss
Exchange (SHLTN, ISIN: IL0010855885, Security No.: 1128957). More information available

For further information please contact:

  • Erez Alroy, Co-CEO, Phone: +972 3561 22 12,
  • Assistant: Pauline Shavit, Phone: +972 3561 22 12,
  • Martin Meier-Pfister, IRF Communications, Phone: +41 43 244 81 40,

Some of the information contained in this press release contains forward-looking statements. Readers
are cautioned that any such forward-looking statements are not guarantees of future performance and
involve risks and uncertainties, and that actual results may differ materially from those in the forward-
looking statements as a result of various factors. SHL Telemedicine undertakes no obligation to
publicly update or revise any forward-looking statements.

(1) Holding percentages calculated excluding treasury shares held by the Company.


Download Full Press Realese